BamSEC and AlphaSense Join Forces
Learn More

Ovid Therapeutics Inc. – Transcripts

NASDAQ: OVID    
Share price (4/8/26): $2.60    
Market cap (4/8/26): $343 million
Search in Documents
Key Exhibits
External Links

Transcripts

CY 2026
Earnings Revised 03/18/26 Ovid Therapeutics Inc., Q4 2025 Earnings Call, Mar 18, 2026 03/18/26
CY 2025
Other Revised 10/03/25 Ovid Therapeutics Inc. - Special Call 10/03/25 Other Revised 06/12/25 Ovid Therapeutics Inc. - Special Call 06/12/25
CY 2024
Other Revised 11/15/24 Ovid Therapeutics Inc. - Special Call 11/13/24
CY 2023
Other Revised 10/02/23 Ovid Therapeutics Inc. - Special Call 10/02/23
CY 2021
Other Revised 06/10/21 Ovid Therapeutics Inc. - Shareholder/Analyst Call 06/10/21 Other Revised 05/19/21 Ovid Therapeutics Inc. Presents at RBC Capital Markets 2021 Global Healthcare Conference, May-19-2021 09:10 AM 05/19/21 Other Revised 03/03/21 Ovid Therapeutics Inc. - Special Call 03/03/21
CY 2020
Other Revised 10/22/20 Ovid Therapeutics Inc. - Special Call 10/22/20 Other Revised 08/25/20 Ovid Therapeutics Inc. - Special Call 08/25/20 Other Revised 07/13/20 Ovid Therapeutics Inc. - Special Call 07/13/20 Other Revised 06/17/20 Ovid Therapeutics Inc. - Special Call 06/17/20 Other Revised 06/04/20 Ovid Therapeutics Inc. - Shareholder/Analyst Call 06/04/20
CY 2019
Other Revised 09/23/19 Ovid Therapeutics Inc. - Special Call 09/23/19 Other Revised 06/27/19 Ovid Therapeutics Inc. - Special Call 06/27/19
CY 2018
Other Revised 12/17/18 Ovid Therapeutics Inc. - Special Call 12/17/18 Other Revised 10/25/18 Ovid Therapeutics Inc. - Special Call 10/25/18 Other Revised 08/06/18 Ovid Therapeutics Inc. - Special Call 08/06/18 Other Revised 05/09/18 Ovid Therapeutics Inc. Presents at 43rd Annual Deutsche Bank Healthcare Conference, May-09-2018 10:40 AM 05/09/18 Earnings Revised 03/29/18 Ovid Therapeutics Inc., Q4 2017 Earnings Call, Mar 29, 2018 03/29/18